is metformin glp 1 vs Ozempic: What's the Difference? Frontiers | Understanding the action
Description
The 12-week randomized and placebo-controlled study was published recently in Frontiers in Nutrition
doi: 10.3389/fendo.2025.1548346 Received 19 December 2024 Accepted 10 February 2025 Published 11 March 2025 Volume 16 - 2025 Edited by Xiaosheng Tan, Rutgers, United States Reviewed by Zilu Chen, Rutgers, The State University of New Jersey, United States Pui Yeung Lee, Yale University, United States Nisi Jiang, University of Texas Southwestern Medical Center, United States Updates Copyright 2025 Mostafa and Alrasheed
Most basic packs stop at a generic questionnaire
December 18, 2024
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial
